Author(s) Yayé, H.Sadou; Hassani, L.; Secrétan, P.H.; Babiard, M.; Aouati, H.; Bellanger, A.; Tilleul, P.; Yagoubi, N.; Do, B.; Rietveld, I.B.
Journal J Pharm Biomed Anal
Date Published 2020 Jan 30

The generic Mylan® etoposide (ETP) has been investigated as an alternative for Etopophos®, in part due to a global shortage of the latter. The generic alternative is different both in its formulation and in its very limited stability (6 h at 25 °C against 4 days for Etopophos®) once reconstituted in ready-to-use chloride or glucose solutions. Its intrinsic stability has been thoroughly studied under various conditions. Two degradation products resulting from hydrolysis were characterized by LC-HR-MS and supported by density functional theory calculations of the frontier molecular orbitals energies, molecular electrostatic potential mapping, and Mulliken charge analysis. Chemical degradation increases with temperature and can be fitted to a zero order kinetic model with a half-life of 119 days and a kinetic constant of 0.0028 mM day. Precipitation was only observed in solutions at 5 °C and -20 °C indicating that at these temperatures the reconstituted solutions are thermodynamically metastable. In conclusion, ETP at concentrations of 0.68 and 1 mM prepared and stored at 25 °C under good manufacturing practices remained unchanged over a period of 21 days irrespective of the nature of the solvents or the type of container.

DOI 10.1016/j.jpba.2019.112896
ISSN 1873-264X
Citation J Pharm Biomed Anal. 2020;178:112896.

Related Applications, Forms & Industries